Remove tag cancer-control
article thumbnail

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. However, at the federal level, cannabinoids remain illegal under the Controlled Substances Act. This is closely followed by CB2 receptors in second place.

Medical 98
article thumbnail

Actualising the power of antibody-drug conjugates as cancer therapeutics

European Pharmaceutical Review

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. cancer agent or disease-relevant toxin. 2 The role of the antibody is to deliver the payload to a specific site such as a cancer cell.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading innovators in peptide nano-particle conjugates for the pharmaceutical industry

Pharmaceutical Technology

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

article thumbnail

How To Sell Effectively In Diagnostic Testing Sales With Kelly Buber

Evolve Your Success

Kelly currently thrives in diagnostic testing sales, specifically in a department that deals with skin cancer prognosis. We’re looking at skin cancer like melanoma and squamous cell carcinoma. We provide a service for cancer patients. That’s a good thing that you don’t have any cancer patients that you’ve seen.

Sales 52
article thumbnail

Unconventional Approaches Pharma Is Taking to Engage Patients

PM360

Considering the motor control issues a person with Parkinson’s might be managing, we put tabs in the booklet to make the pages easy to turn. We also put big pull tags on the little pouches that held the items. “In addition to creating a kit focused on inclusivity, we also wanted to promote accessibility,” Lenn says.

Patients 105
article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

This is in addition to its considerable price tag. Car-t “The living drugs”, immune checkpoint inhibitors, and precision medicine: A new era of cancer therapy. The demand for CAR T-cell therapy is therefore much greater than the supply, making it difficult for patients to access the potentially life-saving treatment. References Liu D.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. You need to do more of a scripted thing.